Application Type
National
Application SubType
(10) Registration Number and Date
10202401108U
Status
ACTIVE ( W10)
(180) Expiration Date
(20) Filing Number and Date
SG 10202401108U 2023.12.31
(40) Publication Number and Date
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US
US63/176,109
2020.12.27
US63/216,418
2021.12.26
US63/305,610
(51) IPC Classes
    (74) Representative
    (54) Title
    (57) Abstract
    (EN)   THIENOPYRROLE COMPOUNDS Abstract The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of an autoimmune disease and/or inflammatory condition, including systemic lupus erythematosus and cutaneous lupus erythematosus. No accompanying figure 572  
    (58) Citations
    License Details
    (98) Annuity Details
    YearValidity StartValidity EndPayment
    Document Type Date Action
    Description (with claims) 2024-04-16T00:00:00Z
    Abstract 2024-04-16T00:00:00Z
    Event NameDateLink
    W102021-12-26
    W102023-12-31
    W102023-12-31
    W102023-12-31